Pfizer Inc. logo

PFE

Pfizer Inc.

PharmaceuticalsDrug Manufacturers - General$152B Market Cap

Biopharmaceutical vaccines, oncology therapeutics, cardiovascular immunology medicines. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
14%Bearish
Buy/Sell Ratio100% buys
BearishBullish
Pfizer Inc. Live QuoteReal-time
$28.06
$2.05(-6.81%)1M
Day Range$28.00 – $28.54
Open$28.06
Previous Close$28.47
Volume37.22M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$162.27B
P/E Ratio (TTM)40.7
Forward P/E9.7
EPS (TTM)$0.70
Price to Book1.8
Dividend Yield7.45%
Beta (Volatility)0.30
IndustryDRUG MANUFACTURERS - GENERAL
52-Week RangeCurrent: $28.06 (64%)
Low: $22.76High: $30.99
Wall Street Consensus
Buy
Analyst Rating
4.1/ 5.0
Target Price
$30.22+12.8% upside

Insider Buys

1

$2.96M

Insider Sales

0

$0

Total Volume

$2.96M

7 transactions

Net Activity

+$2.96M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
75CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

3 Insiders

1 buys6 sells

$17.20B total

Trading History
PFE insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 12, 2026

3 months ago

Multiple Insiders

3 Insiders

Insider
Buy114.9K$25.77$2.96M

Aug 12, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell435.6K$38000.00$16.55B

Aug 5, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell28.6K$-3278.00$0

Jun 9, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell31.4K$-2000.00$0

Mar 4, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell11.8K$-2500.00$0

Feb 13, 2025

21 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell32.5K$19457.00$631.52M

Oct 30, 2024

25 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell10.0K$1000.00$10.00M
Sector & Industry Benchmarks
Pharmaceuticals Comparison Overview
Industry Buy Conviction0%
PFE Buy Conviction100%
Industry Rank#0 of 1
Volume Contribution24.8%
Total Industry Activity$11.93M

PFE has an insider buy conviction of 100%, compared to the Pharmaceuticals sector buy average of 0%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PFE

Over the last 90 days, corporate insiders at Pfizer Inc. (PFE) engaged in a total of 7 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $2.96M.

The net insider activity for PFE shows a net buying bias of $2.96M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 435.6K shares valued at $16.55B on Aug 12, 2026.

Live Market News & Developments
Aggregated real-time headlines for Pfizer Inc. (PFE)
6 updates

One Unsettled Question Sits Under Pfizer Stock

Yahoo Finance2d ago

Pfizer (PFE) Re Enters Obesity Drugs With Metsera Acquisition

Yahoo Finance2d ago

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

Yahoo FinanceYesterday

Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know

Yahoo Finance40d ago

Pfizer (PFE) Stock Sinks As Market Gains: Here's Why

Yahoo Finance21d ago

Pfizer (PFE) Stock Looks Overvalued On Its 29% One Year Gain

Yahoo Finance9d ago

FAQs About Pfizer Inc. Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PFE.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PFE is currently 75/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for PFE is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.